Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Harvard Business School
Farmers Insurance
Daiichi Sankyo
Cantor Fitzgerald

Generated: January 22, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: terbinafine hydrochloride

« Back to Dashboard

terbinafine hydrochloride Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Mylan terbinafine hydrochloride 077136 EQ 250MG BASE TABLET;ORAL
Roxane terbinafine hydrochloride 077223 EQ 250MG BASE TABLET;ORAL
Andrx Pharm terbinafine hydrochloride 076713 EQ 250MG BASE TABLET; ORAL
Gedeon Richter Usa terbinafine hydrochloride 077065 EQ 250MG BASE TABLET;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.